$8B GLP-1 Genetic Market by 2030 (Nomura projection) 3
Semaglutide 1,2 , a long-acting glucagon-like peptide-1 (GLP-1) analogue, traditionally used for the treatment of diabetes, has recently emerged as an efficient therapeutic agent for obesity 3
This means seeking solutions when problems are too often advanced, expensive, or too late to treat
By completing your purchase, you acknowledge that Melanotan I (Afamelanotide) is an investigational material not approved for general medical or therapeutic use by any regulatory authority
However, this same mechanism is directly responsible for many of the gastrointestinal side effects associated with the medication
While occasional flutters can be normal, frequent or severe palpitations, especially when accompanied by symptoms like chest pain or dizziness, may require attention